Avantax Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.26M Buy
15,177
+142
+0.9% +$11.9K 0.01% 1017
2025
Q1
$1.26M Buy
15,035
+229
+2% +$21.3K 0.01% 970
2024
Q4
$1.36M Buy
14,806
+77
+0.5% +$7.41K 0.01% 900
2024
Q3
$1.37M Sell
14,729
-310
-2% -$26.9K 0.01% 863
2024
Q2
$1.24M Buy
+15,039
New +$1.1M 0.01% 874
2022
Q1
Sell
-9,452
Closed -$475K 1333
2021
Q4
$475K Hold
9,452
0.01% 781
2021
Q3
$501K Sell
9,452
-148
-2% -$8.34K 0.01% 723
2021
Q2
$586K Buy
9,600
+2,707
+39% +$144K 0.01% 643
2021
Q1
$335K Buy
6,893
+208
+3% +$9.75K 0.01% 764
2020
Q4
$272K Buy
+6,685
New +$239K 0.01% 767

Other funds holding LMAT

Avantax Advisory Services's LMAT Position: Q2 2025 in Review

Avantax Advisory Services increased its LeMaitre Vascular (LMAT) stake by 0.94% in Q2 2025, buying an estimated $11.9K and bringing the position to 15,177 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #1017.

Avantax Advisory Services first reported a position in LMAT in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.37M in Q3 2024. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Avantax Advisory Services held 15,177 shares of LeMaitre Vascular worth $1.26M as of Q2 2025.
  • Avantax Advisory Services bought 142 LeMaitre Vascular shares in Q2 2025, an estimated $11.9K.
  • LeMaitre Vascular made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1017 holding.
  • Avantax Advisory Services first reported a position in LeMaitre Vascular in Q4 2020 and has held it in 10 quarters since.
  • Avantax Advisory Services's LeMaitre Vascular position peaked at $1.37M in Q3 2024.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.